Netherlands Translational Research Center

Oncolines is a precision medicine services company in oncology and cancer immunotherapy. We offer a set of complementary services to enable our clients to determine the activity, selectivity and mechanism of action of drugs and drug candidates. Our technology platforms for services comprise cancer cell panel profiling, drug combination testing, bioinformatics, flow cytometry, DNA and RNA sequencing, generation of drug resistant cell lines, target residence time determination, kinase profiling and more. We are experts in the discovery of drug response biomarkers. With Oncolines® cancer cell panel profiling and bioinformatics, we identify predictive drug response biomarkers, new disease indications and synergistic drug combinations. We present data in a unique interactive reporting format to facilitate easier and faster interpretation of results. We help cancer researchers to move their projects to the clinic faster.